SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-16-080305
Filing Date
2016-02-10
Accepted
2016-02-10 14:21:09
Documents
1
Group Members
DAVID L. DOUGLASSDEEPIKA R. PAKIANATHANDELPHI BIOINVESTMENTS VII, L.P.DELPHI BIOINVESTMENTS VIII, L.P.DELPHI MANAGEMENT PARTNERS VII, L.L.C.DELPHI MANAGEMENT PARTNERS VIII, L.L.C.DELPHI VENTURES VII, L.P.DOUGLAS A. ROEDERJAMES J. BOCHNOWSKI

Document Format Files

Seq Description Document Type Size
1 SC 13D v430868_sc13d.htm SC 13D 142541
  Complete submission text file 0001144204-16-080305.txt   144619
Mailing Address 3910 BRICKWAY BOULEVARD SANTA ROSA CA 95403
Business Address 3910 BRICKWAY BOULEVARD SANTA ROSA CA 95403 707-543-8800
TriVascular Technologies, Inc. (Subject) CIK: 0001432732 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-88098 | Film No.: 161404889
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 3000 SAND HILL ROAD BUILDING 1, SUITE 135 MENLO PARK CA 94025
Business Address 3000 SAND HILL ROAD BUILDING 1, SUITE 135 MENLO PARK CA 94025 650-854-9657
DELPHI VENTURES VIII LP (Filed by) CIK: 0001436285 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: SC 13D